Repligen reported $976M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agilent A:US $ 3690M 47M
Align Technology ALGN:US $ 2376.8M 103.96M
Bio Techne TECH:US $ 605.56M 12.45M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bristol Myers Squibb BMY:US $ 30186M 65M
Bruker BRKR:US $ 2087.5M 163.3M
Catalent CTLT:US $ 2916M 109M
Charles River Laboratories CRL:US $ 1393.09M 60M
Danaher DHR:US $ 13229M 559M
Exact Sciences EXAS:US $ 1101.63M 113.5M
Fluidigm FLDM:US $ 250.88M 177.68M
General Electric GE:US 60.66B 2.64B
Henry Schein HSIC:US $ 3789M 41M
Illumina ILMN:US $ 2891M 136M
IQVIA Holdings Inc IQV:US $ 4.91B 139M
Mettler Toledo International MTD:US 1.32B 14.82M
Myriad Genetics MYGN:US $ 367.1M 60.3M
Nanostring Technologies NSTG:US $ 354.7M 32.43M
Orasure Technologies OSUR:US $ 267.31M 1.06M
Pacific Biosciences Of California PACB:US $ 969.99M 59.2M
Patterson Companies PDCO:US $ 1705.98M 26.96M
Peregrine Pharmaceuticals PPHM:US $ 180.64M 0.61M
Perkinelmer PKI:US $ 2107.77M 346.74M
Repligen RGEN:US $ 976M 31.21M
Thermo Fisher Scientific TMO:US $ 18100M 676M
Waters WAT:US $ 1469.17M 116.01M
West Pharmaceutical Services WST:US $ 1771.1M 80.6M